Moonpay buys Decent, launches trade for 200+ chains
Moonpay acquired Decent and on May 21, 2026 launched Moonpay Trade, an API-based cross-chain execution platform giving institutions access to 200+ blockchains.
Moonpay acquired Decent.xyz and on May 21, 2026 launched Moonpay Trade, a cross-chain execution platform that gives banks, asset managers and enterprises access to more than 200 blockchains and protocols through a single API integration. The platform is aimed at regulated financial firms and institutional applications that need onchain execution, settlement and conversion.
Moonpay Trade combines Decent’s bridge infrastructure, routing algorithms and aggregation layer with Moonpay’s payments and compliance systems. The service routes transactions across networks including Ethereum, Solana, Base, Hyperliquid and Bitcoin, supports fiat-to-onchain settlement in over 120 currencies and includes KYC/AML and reporting capabilities for institutional users.
Decent.xyz, founded in 2021 and backed by Y Combinator, Archetype and Circle, provided the cross-chain routing technology Moonpay bought. The acquisition added tools that consolidate liquidity spread across chains, venues and protocols into a single integration for clients that do not maintain direct links to multiple execution venues.
Moonpay Trade will serve as the execution layer for Moonpay Institutional, the company’s unit for regulated financial services firms led by Caroline D. Pham, the former acting chair of the Commodity Futures Trading Commission. Caroline D. Pham said, “Every major financial institution is building a tokenized asset strategy,” and described Moonpay Trade as a single compliance-backed technology path to onchain markets.
The platform links with Moonpay’s recent purchase of DFlow, a Solana-native trading infrastructure provider that processed more than $12 billion in trading volume in the first quarter of 2026. According to Moonpay, combining Decent and DFlow expands execution coverage across EVM-compatible and Solana-native markets and increases routing and settlement options for institutional flow.
Ivan Soto-Wright, Moonpay co-founder and CEO, described Moonpay Trade as bringing payments, execution and settlement together on one platform for institutions and enterprises. Charlie Durbin, Decent co-founder and CEO, described the technology as delivering real-time routing and execution across 200-plus chains to reduce fragmentation and connect fiat and onchain rails.
Moonpay Trade includes a proprietary automated market maker built for stablecoin trades that offers 1:1 quotes for API-routed transactions. The liquidity layer supports onchain subscriptions and redemptions for tokenized funds and integrates yield-generating vaults on platforms such as Morpho, Aave and Maple Finance. The system can move collateral across permissioned and permissionless networks while capturing compliance and reporting data required by institutional users.
Industry data show tokenized real-world assets on public ledgers have passed $33 billion in onchain value. Consulting projections estimate the market for tokenized assets could reach $14 trillion by 2030 and $55 trillion by 2035. Total value locked in DeFi protocols exceeds $100 billion, and several institutional fund managers have launched tokenized funds on public blockchains.
Moonpay has completed more than six acquisitions in the past 18 months across payments, stablecoins, custody and trade execution. Company executives describe Moonpay Trade as part of an effort to provide an end-to-end technology stack for regulated firms that lack the engineering resources to build direct connections to a wide range of chains and liquidity venues.
The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.







